EBEkaterina V. Boeva

Ekaterina V. Boeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekaterina V. Boeva has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analysis of some polymorphic IL-6, IL-10 gene variants in individuals with psychoneurological manifestations of long COVID

    by Anna V. Sedykh, Kristina Y. Shchepotkina, Yulia V. Ostankova, Vadim V. Rassokhin, Ekaterina V. Zagalskaya, Anastasia A. Knizhnikova, Anna O. Norka, Natalia V. Halinouskaya, Nikolay A. Belyakov, Щепоткина Кристина Юрьевна, et al.

    The aim of the study was to investigate the characteristics of psychoneurological status and allelic distribution of some polymorphic loci in the IL-6 (interleukin-6), IL-10 (interleukin-10) genes in patients with long COVID. Materials and methods. The study group consisted of 130 patients (aged 18–60) with a known history of COVID-19 and a temporal association between the disease and the development of health complaints. The control group included 116 individuals with no acute infectious or somatic pathologies, chronic diseases, or complaints about somatic or mental health. The genetic markers examined were polymorphic variants of rs1800795 (IL-6) and rs1800871 (IL-10). Nucleotide sequences including these SNPs were obtained using direct Sanger sequencing. Results. Psychoneurological symptoms in individuals with long COVID occurred in 1/3 cases and were characterized by pronounced polymorphism. Significant intergroup differences were found in the genotype distribution of the IL-6 gene polymorphism (–174GC) (p 0.0001). A marked reduction in the frequency of the “wild-type” homozygous GG genotype was observed (6.92% vs 28%; p 0.001), which may reflect its potential protective role against developing neuro-COVID complications or association with the severe COVID-19. A predominance of the heterozygous GC genotype was found in the study group (69.23% versus 50%; p = 0.0032). Analysis of IL-10 genotype (–819CT) distribution also revealed differences between the groups (p = 0.0388). Conclusion. Damage to the nervous system largely determine the clinical symptoms of post-COVID disorders. The role of polymorphic variants (–174GC) of IL-6 (rs1800795) and (–819CT) of IL-10 (rs1800871) in modulating the immune response and the pathogenesis of post-COVID syndrome has been identified.

  • Open Access

    Editorial article based on the results of the study human herpes virus reactivation in the pathogenesis of long COVID

    by E. V. Boeva, V. V. Rassokhin, A. O. Norka, A. A. Knizhnikova, Z. R. Korobova, N. A. Arsent’yEva, A. R. Ivanova, А. М. Клементьев, N. A. Belyakov

    The analytical review allows us to look at the problem of long-term consequences of coronavirus infection from the standpoint of synergistic interaction of herpesvirus pathogens and SARS-CoV-2. The authors provide data of the incidence of long-term post-COVID syndrome (Long COVID), the prevalence of herpesvirus diseases, and possible pathogenetic and clinical intersections in the formation of post-viral consequences in humans. The variety of clinical manifestations of Long COVID, possible causes of these symptoms are described, and data of the potential role of human herpesviruses in the development of central nervous system lesions and the formation of cognitive impairment are presented. Particular attention is paid to the immunological link in the pathogenesis of a number of herpes-associated diseases and Long COVID. Currently, not all mechanisms of damage to organs and systems in post-COVID syndrome have been studied and discovered, especially with the mutually aggravating effects of coronaviruses and human herpesviruses. Further research will provide new information and a more complete picture of cause-and-effect relationships in describing and explaining the immediate and long-term consequences of the viral infections under consideration, the formation of Long COVID, as well as potential targets for in-depth examination of patients and therapeutic measures.


  • Open Access

    T Cell Dynamics in COVID-19, Long COVID and Successful Recovery

    by Zoia R. Korobova, Natalia A. Arsentieva, Anastasia A. Butenko, Igor V. Kudryavtsev, Artem A. Rubinstein, Anastasia S. Turenko, Yulia V. Ostankova, Ekaterina V. Boeva, Anastasia A. Knizhnikova, Anna O. Norka, et al.

    Despite targeting mainly the respiratory tract, SARS-CoV-2 disrupts T cell homeostasis in ways that may explain both acute lethality and long-term immunological consequences. In this study, we aimed to evaluate the T-cell-mediated chain of immunity and formation of TCR via TREC assessment in COVID-19 and long COVID (LC). For this study, we collected 231 blood samples taken from patients with acute COVID-19 (n = 71), convalescents (n = 51), people diagnosed with LC (n = 63), and healthy volunteers (n = 46). With flow cytometry, we assessed levels of CD4+ and CD8+ minor T cell subpopulations (i.e., naïve, central and effector memory cells (CM and EM), Th1, Th2, Th17, Tfh, Tc1, Tc2, Tc17, Tc17.1, and subpopulations of effector cells (pE1, pE2, effector cells)). Additionally, we measured TREC levels. We found distinct changes in immune cell distribution—whilst distribution of major subpopulations of T cells was similar between cohorts, we noted that COVID-19 was associated with a decrease in naïve Th and CTLs, an increase in Th2/Tc2 lymphocyte polarization, an increase in CM cells, and a decrease in effector memory cells 1,3, and TEMRA cells. LC was associated with naïve CTL increase, polarization towards Th2 population, and a decrease in Tc1, Tc2, Em2, 3, 4 cells. We also noted TREC correlating with naïve cells subpopulations. Our findings suggest ongoing immune dysregulation, possibly driven by persistent antigen exposure or tissue migration of effector cells. The positive correlation between TREC levels and naïve T cells in LC patients points to residual thymic activity. The observed Th2/Th17 bias supports the hypothesis that LC involves autoimmune mechanisms, potentially driven by molecular mimicry or loss of immune tolerance.


  • Open Access

    B Cell Dynamics and Transitional B Cells in Long COVID

    by Zoia R. Korobova, Natalia A. Arsentieva, Natalia E. Liubimova, Oleg K. Batsunov, Anastasia A. Butenko, Albina E. Kokoeva, Natalia G. Kucherenko, Victor A. Kashchenko, Ekaterina V. Boeva, Anna O. Norka, et al.

    Background: Long COVID is characterized by persistent symptoms following acute SARS-CoV-2 infection. This study aims to evaluate immune system markers, including antigen-specific antibodies, B cell subsets, and Th2-related cytokines, in individuals with long COVID and to investigate their potential impact on the development of this condition. Methods: We analyzed blood plasma from 63 individuals diagnosed with long COVID based on clinical presentation and 47 healthy individuals with COVID-19 history but no clinical symptoms. Antigen-specific IgG antibodies were measured using commercial ELISA kits. Lymphocyte subpopulations were assessed via flow cytometry and a gating strategy based on CD27 and CD38. Th2 cytokines (IL-4, IL-5, IL-13) were quantified using the xMAP multiplex assay. Results: We noted no significant differences in IgG levels between groups. Notably, individuals with long COVID demonstrated a higher percentage of naive mature B cells (CD27−CD38+), while transitional (CD27−CD38+++) and double-negative (DN, CD27−CD38-) cells were significantly reduced. Elevated levels of IL-5 and IL-13 were observed in long COVID patients. Classification analysis revealed that the percentage of transitional B cells (CD27−CD38+++) was a strong predictor of long COVID. Conclusions: Our findings highlight alterations in B cell dynamics among individuals with long COVID, which may contribute to autoimmune processes.


  • Open Access

    Immune dysregulation in long covid may contribute to the development of neurological disorders through the effects of cytokines

    by V. V. Rassokhin, N. A. Arsentieva, Z. R. Korobova, N. E. Lyubimova, O. K. Batsunov, E. V. Boeva, A. A. Knizhnikova, A. O. Norka, N. B. Khalezova, N. A. Belyakov

    Aim of the study: to investigate the role of proinflammatory markers and some immune cells in neural and cognitive disorders in long COVID patients.Materials and methods. The study included 81 patients diagnosed with long COVID, the presence of which was determined by the persistence of a complex of multidirectional symptoms for more than 12 weeks that developed during or after COVID-19. Flow cytometry was used to assess lymphocyte subsets. The main lymphocyte subpopulations were analyzed: T cells, cytotoxic T cells, B cells, NK and NKT cells in blood plasma via multiplex xMAP analysis. Also concentrations of GM-CSF, IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-12, IL-13, IL-17, MCP-1, MIP-1b, TNF were measured. The content of proinflammatory cytokines and some immune system cells was characterized in respondents with long COVID. A comparative analysis of data was conducted with individuals without a history of COVID-19, as well as between patients with different numbers of SARS-CoV-2 cases.Results and discussion. The study identified characteristic features of long COVID that affect both the nervous and immune systems.Analysis of the blood cells revealed absolute and relative lymphopenia due to a decrease in NK cells. We also noticed an increased number of NKT cells in patients who suffered multiple COVID-19, when compared to those who only were infected with SARS-CoV-2 once. Cytokine analysis revealed increase in concentrations of IL-5, IL-8, IL-13, IL-17 and CCL2/MCP1 in blood plasma of long COVID patients.Conclusion. The data provides additional support to the theory of immune dysregulation in neurological symptoms of long COVID.


  • Open Access

    Neuropsychiatric consequences and radiological manifestations of COVID-19

    by T. N. Trofimova, A. A. Bogdan, E. I. Vinogradova, V. V. Rassokhin, E. V. Boeva, A. A. Knizhnikova, Ya. B. Kushnir, A. O. Norka, A. M. Yurkovsky, N. A. Belyakov

    INTRODUCTION: In people who have experienced a new coronavirus infection (COVID-19), long COVID disorders can manifest as persistent cognitive and neuropsychiatric disorders that endanger daily activities and psychosocial adaptation. The long-term persistence and polymorphism of symptoms after COVID-19 is a growing concern. It is characterized by undulation, when some of the symptoms may temporarily disappear and then return again. As of 2024, the prevalence of long COVID is 6–7% in adults and about 1% in children. Using neuroimaging techniques is an integral part of the timely diagnosis of acute disorders and consequences associated with COVID-19.OBJECTIVE: To assess the nature of health complaints, features of neurological and cognitive disorders and compare them with radiological changes in the brain in people in the post-COVID period.MATERIALS AND METHODS: For the period from 2023–2024, 170 patients aged 18 to 60 years participated in the study, with a history of established fact of COVID-19, confirmed by polymerase chain reaction (PCR) SARS-CoV-2. The main socio-demographic and clinical and laboratory indicators were evaluated for all participants, with further radiological examination. As part of the neuropsychological examination, the Montreal Cognitive Assessment Scale (MoCA), «10 words» by A.R. was evaluated. Luria, «Schulte Tables», neuropsychological tests to study the state of praxis and the state of various aspects of gnosis, as well as a subjective assessment of 38 symptoms, which included: memory impairment, concentration, fatigue, anxiety, the presence of panic attacks, pain of various localizations, etc. The neuroimaging examination included structural MRI and 1 H-MRI, performed on a SIGNA Architect 3 Tl tomograph (GE HealthCare, General Electric, USA).RESULTS: The majority of the (n=170) was represented by women (80%). Over 2⁄3 of the respondents belonged to the working-age population; the average age was 38.2±11.3 years. The most common symptoms of the acute phase of NCI were: an increase in body temperature above 38˚C, shortness of breath during physical exertion, and impaired consciousness. Most often in the post-COVID period, patients presented the following non-specific complaints: hair loss (56.6%), decreased/increased appetite (52.6%), pain in different parts of the abdomen (45.7%), fluctuations in blood pressure, the frequency of which increased with increasing age (pDISCUSSION: The results obtained within the framework of neurological and neuropsychological examination indicate the presence of a predominantly modal-nonspecific factor lesion, that is, changes in the processes of activation/inactivation of brain structures, contributing, among other things, to the occurrence of the above-mentioned anxiety and depressive states. The described disorders indicate the leading role of damage to the structures of the first block of the brain according to A.R. Luria, indicating the presence of damage in persons in the postcovid period in the area of the mediobasal cortex of the frontal lobes, hippocampus, and stem structures. In addition, imaging ultrastructural data (MRS) has the potential to be a neuromarker of manifestations of post-COVID neurological syndrome.CONCLUSION: Post-COVID syndrome is characterized by multi-systemic manifestations, while central nervous system lesions can be attributed to the most common complications of infection caused by SARS-CoV-2. The conducted study demonstrates the high frequency and versatility of manifestations of post-COVID disorders on the part of the nervous system, regardless of the severity of the disease, which in some cases were reflected in the framework of radiological studies. Future work involves the use of complex clinical, radiological, laboratory immunological, virological and genetic techniques to search for predisposing factors, understand the mechanism of pathogenesis, and possible ways to influence and prevent the development of postcovid syndrome.


  • Open Access

    Long-term neuropsychological and pathopsychological consequences associated with COVID-19

    by Nikolay A. Belyakov, Vadim V. Rassokhin, Ekaterina V. Boeva, Anastasia A. Knizhnikova, Anna O. Norka, Nadezhda B. Khalezova, Yana B. Kushnir, Elena R. Isaeva

    Introduction. Long-term consequences associated with COVID-19 have a significant impact on people’s health. The most common symptoms observed in the post-COVID period include disorders of the nervous system (21.7 %). However, data on the mental structure of the consequences induced by SARS-CoV-2 is still lacking. The purpose of this study was therefore to assess the structure and nature of health complaints as well as neuropsychological and pathopsychological disorders in people in the post-COVID period. Materials and Methods. This article presents the results of an extensive survey involving 1,200 respondents, which aimed to identify the main general somatic, mental and neurological consequences that developed from four weeks to twelve months after COVID-19 infection. Another part of the described results comes from an experimental psychological examination of 47 respondents randomly selected from the main study group (n = 1,200), which included an assessment of the overall state of cognitive functions, memory, attention, gnosis, praxis and the severity of psychopathological symptoms. Results. A total of seven subphenotypes of disorders were identified in the post-COVID period, among them anxiety and related phenomena (1), neuromuscular disorders associated with pain syndrome (2), disorders of respiratory, cardiovascular and autonomic systems (3), asthenic phenomena (4), disorders of cognitive functions (5), depressive phenomena (6) and disorders of sensory organs (7). The experimental psychological examination revealed the following mental disorders: a decline in logical and mechanical long-term memory, a decrease in mental stability, difficulties in spatial gnostic and praxic orientations, the severity of anxious and depressive tendencies and a proclivity for obsessive phenomena. Conclusions. Rehabilitation of persons with a history of COVID-19 infection requires a comprehensive neuropsychological correction program rooted in a multidisciplinary approach. The identified subphenotypes and mental disorders of the post-COVID period can be used as corrective targets in rehabilitation. Введение. Отсроченные последствия, ассоциированные с COVID-19, оказывают значимое влияние на состояние здоровья населения. Лидирующие позиции среди симптомов постковидного периода занимают нарушения со стороны нервной системы (21,7 %). При этом данных о психической структуре последствий SARS-CoV-2 на сегодняшний день недостаточно. В связи с этим целью исследования была оценка структуры и характера жалоб на состояние здоровья, а также нейропсихологических и патопсихологических нарушений у людей в постковидный период. Материалы и методы. В статье приводятся результаты расширенного анкетирования 1200 респондентов, которое было направленно на выявление основных общесоматических, психических и неврологических последствий, развившихся в период от 4 недель до 12 месяцев после перенесенного COVID-19. Другая часть описываемых результатов относится к экспериментально-психологическому обследованию 47 респондентов, случайным образом отобранных из основной группы исследования (n = 1200), включавшему оценку общего состояния когнитивных функций, памяти, внимания, гнозиса, праксиса, а также выраженности психопатологической симптоматики. Результаты исследования. С повышением возраста увеличивалась тяжесть протекания как острой фазы, так и отсроченных последствий перенесенной новой коронавирусной инфекции. Было выявлено семь субфенотипов нарушений в постковидном периоде, включающих в себя тревожные и сопряженные подобные явления (1), нервно-мышечные нарушения, сопряженные с болевым синдромом (2), нарушения дыхательной, сердечно-сосудистой и вегетативной систем (3), астенические явления (4), нарушения со стороны когнитивных функций (5), депрессивные явления (6), нарушения со стороны органов чувств (7). В рамках экспериментально-психологического обследования были выявлены следующие психические нарушения: снижение логической и механической долговременной памяти, снижение психической устойчивости, трудности пространственных гностических и праксических ориентировок, выраженность тревожных и депрессивных тенденций, склонность к навязчивым явлениям и выраженному дискомфорту от наличных соматических...


  • Open Access

    Postcovid syndrome in residents of North-West Russia: clinical, laboratory and neuropsychiatric consequences

    by N. A. Belyakov, V. V. Rassokhin, E. V. Boeva, A. A. Knizhnikova, A. A. Norka, N. B. Khalezova, E. I. Vinogradova, Ya. I. Kushnir, Я. Б. Кушнир

    The aim. To analyze anamnestic data, clinical and laboratory parameters, and psychoneurological manifestations in patients in the post-COVID period.Materials and methods. After the initial survey of 1,200 respondents who had suffered from a new coronavirus infection (COVID-19), a group of 170 patients was identified based on the presence of complaints about the state of somatic and mental health that have a temporary relationship with the SARS-CoV-2 disease. As part of the study, this group of patients underwent a comprehensive laboratory examination with an assessment of general clinical and biochemical parameters, inflammatory markers and the blood coagulation system. All patients were examined by an infectious disease specialist, a neurologist, a psychiatrist-narcologist and a medical psychologist. The main socio-demographic and clinical laboratory data in the post-COVID period, as well as neurological and psycho-emotional characteristics obtained from 130 participants in 2024, were assessed. In order to study cognitive and executive functions, psycho-emotional state, the following methods were used: Montreal Cognitive Assessment (MoCA), Hospital Anxiety and Depression Scale (HADS) and SCL-90 Symptomatic Questionnaire. In addition, each respondent was asked to determine the presence and severity of the main psychopathological, neurological, cognitive and general somatic symptoms using the «Not bothered-Weakly-Moderately-Extremely» scale specially developed for the study, which included up to 38 symptoms.Results and discussion. The majority of the sample were women (80%). Over 2⁄3 of the respondents were of working age, with an average age of 38.2±11.3 years, and 65.3% had mild forms of COVID-19. Repeated cases of COVID-19 were associated with a high risk of blood saturation decrease to ≤93% (pConclusion. Comparison of the results of the questionnaire and in-depth study showed that cognitive and psychoneurological disorders are widespread among patients of different age groups, regardless of the severity of the COVID-19. Given the mechanism of direct and indirect effects of SARS-CoV-2 on the brain, it is the symptoms of damage to the nervous system, including cognitive functions and the psychoemotional sphere, that largely determine the clinical symptoms of post-COVID disorders. The complexity and versatility of clinical and laboratory manifestations of post-COVID syndrome require the involvement of specialists of various profiles in working with patients, the need to develop protocols and recommendations for working with people with manifestations of post-COVID syndrome.


  • The evolution and causes of the change in the demographic model of Russia. Message 1. General assessment of historical, medical, social and demographic events

    by Nikolay A. Belyakov, Tatyana N. Trofimova, Eduard K. Ailamazyan, Ekaterina V. Boeva, Andrey L. Vassoevich

    The demographic situation in different periods was determined by the general patterns of childbearing, epidemics and the state of society. In Russia, even against the background of great upheavals, population growth has been observed for several centuries with a high birth rate, which exceeded the total mortality rate. Epidemics, wars and political events of the twentieth century, as well as the change of priorities in the 1990s, left their mark and led to a decrease in the population. This analytical review is devoted to the evolutionary changes in the Russian population model. The main historical, medical, social and demographic events that dynamically affect the demographic situation in our country are considered. Special attention is paid to the factors influencing the decline in the population in the country, which must be taken into account when planning and implementing state and territorial programs to stimulate the birth rate, taking into account the main political and economic changes.

  • Open Access

    Delayed mental, neurological and somatic disorders associated with COVID-19

    by N. A. Belyakov, V. V. Rassokhin, N. A. Totolyan, E. V. Boeva, A. S. Bobreshova, N. B. Khalezova, Ya. B. Kushnir, A. O. Norka

    Purpose of the study. To assess the nature of health complaints, frequency of occurrence, structure and characteristics of neurological, general somatic and mental disorders in people in the post-COVID period.Materials and methods. The main group (n=1000) was represented by people who had a new coronavirus infection, confirmed by polymerase chain reaction (PCR) SARS-CoV-2, from 18 to 60 years old. As part of the study, an extensive survey of the examined individuals was carried out, aimed at identifying the main psychoneurological and general somatic consequences that developed in the period from 4 weeks to 12 months after COVID-19.Results and discussion. The study included 289 men and 711 women (28.9% and 71.1%, respectively). The average age at the time of the examination was 40.2±11.8 years. More than half of the respondents were of working age, had a permanent job or were studying (72.3%), while 17.9% indicated a high level of physical activity before COVID-19. The majority of respondents suffered from mild COVID-19 (76.6%), in 23.4% of cases the disease was moderate. Among somatic (vegetative) disorders as a consequence of COVID-19, the most common complaints were hair loss (49.5%), fatigue in 77.5% of cases, regardless of workload and type of work, and fluctuations in blood pressure in 50.2% of patients. Women complained more intensely about hair loss (χ2=60.2608, df=9, p<.001), shortness of breath (χ2=17.5025, df=9, p=0.04), interruptions in heart function (χ2=22.7863, df=9, p=0.007).Among the respondents, the most common complaints were emotional disturbances, which determined the picture of anxiety and depressive disorders, as well as cognitive impairments in the form of memory loss (69.5%), concentration, difficulties with long-term attention maintenance (65,5%) and switching from one task to another (60%). With the age of the respondents, fatigue increased in intensity (R=0.2, p2=23.8901, df=9, p=0.004), general malaise (χ2=17.9304, df=9, p=0.04) and, accordingly, lower activity and inability to cope with household workload (χ2=22.3384, df=9, p=0.008) compared to men. Women had more severe dysmnestic disorders (χ2=23.0900, df=9, p=0.006) than men. Women were also characterized by having greater anxiety for close persons (χ2=20.5941, df=9, p=0.01) and insomnia (χ2=20.2633, df=9, p=0.02) than men. Post-COVID neurological disorders, despite their lower frequency and intensity of manifestations, caused the most significant difficulties in everyday life and predominated in older people.Conclusion. The clinical picture of post-COVID syndrome is represented by a wide range of somatic and neuropsychiatric disorders, which determines the specifics of patient management after the illness. When assessing long-term disorders, it is advisable to rely on the opinions of specialists as part of an interprofessional expert group, to make decisions on the implementation of a clinical diagnostic algorithm for each patient based on a systematic approach, taking into account specific symptoms or conditions. Preliminary results of our study showed that special attention should be paid to women at the stage of treatment of acute infection and rehabilitation, due to the higher incidence of psychoneurological complications of COVID-19 in them. Given the risks of long-term consequences of COVID-19 and the possibility of reinfection, it is critical to integrate basic and clinical research data to optimize cognitive preservation and quality of life for patients.